Eterna Therapeutics Inc.
ERNA
$-0.09
Change (1 day)
$2.63
Year High
$0.52
Year Low
Categories
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. Brooklyn ImmunoTherapeutics, Inc. is based in Brooklyn, New York.
Stock split history for Eterna Therapeutics Inc. (ERNA)
Eterna Therapeutics Inc. stock (symbol: ERNA) underwent a total of 3 stock splits.
The most recent stock split occured on Oct 17, 2022.
Annual Revenue
| Date | Splite | Multiple |
|---|---|---|
| 2022-10-17 | 1:20 | 1 |
| 2021-03-26 | 1:2 | 1 |
| 2016-06-17 | 1:50 | 1 |